• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy
• Books
• Gallery

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Hyderabad, Sept. 14

Pharma major Dr Reddy’s Laboratories Ltd had received approval for anti-diabetic Nateglinide tablets from the US Food and Drug Administration. “We have received the approval and the product has already been launched,” a company spokesperson said. The Hyderabad-based company was among the first-to-filers for the product and is eligible for 180-day exclusivity. “The would be shared exclusivity,” the company said. —

Our Bureau

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line